Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 42 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Vlachaki, Efthymia [Clear All Filters]
(2009).
High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes..
Acta Haematol. 124(3), 141-9.
(2010). Haematoma caused by bone marrow aspiration and trephine biopsy..
Hematol Rep. 3(3), e25.
(2011). Pure red cell aplasia and lymphoproliferative disorders: an infrequent association..
ScientificWorldJournal. 2012, 475313.
(2012). Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia..
Case Rep Hematol. 2014, 213631.
(2014). Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition..
Transfus Apher Sci. 51(2), 175-7.
(2014). Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis..
Clin Gastroenterol Hepatol. 13(1), 55-63.e5.
(2015). Evaluation of Mental Health and Physical Pain in Patients with β-Thalassemia Major in Northern Greece..
Hemoglobin. 39(3), 169-72.
(2015). Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major..
Hemoglobin. 39(5), 299-304.
(2015). Relationship between Helicobacter pylori infection and multiple sclerosis..
Ann Gastroenterol. 28(3), 353-356.
(2015). Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?.
Acta Haematol. 133(1), 78-82.
(2015). A Case of Fatal Agranulocytosis That Developed in a Patient with β-Thalassemia Major Treated with Deferiprone..
Hemoglobin. 40(6), 435-437.
(2016). Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?.
Int J Hematol. 103(5), 537-44.
(2016). The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?.
Turk J Haematol. 33(2), 88-93.
(2016). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.
European Journal of Haematology. 98111125151171328622526459851317339343312102118301141312212432349259292117201512520158233100(6), 563 - 568.
(2017). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis..
Eur J Haematol. 98(6), 563-568.
(2017). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients..
Ann Hematol. 96(11), 1937-1944.
(2017). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
(2017). evidence of complement activation in patients with sickle cell disease..
Haematologica. 102(12), e481-e482.
(2017). A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke..
Sleep Med. 34, 256.
(2017). Presence of the IVS-I-6-Mutated Allele in Beta-Thalassemia Major Patients Correlates with Extramedullary Hematopoiesis Incidence..
Acta Haematol. 137(3), 175-182.
(2017). Rivaroxaban Use in Patients with Hemoglobinopathies..
Hemoglobin. 41(3), 223-224.
(2017). A Time Course of Bevacizumab (Anti-VEGF) Effect on Rat Peritoneum: Relations Between Antiadhesive Action and Fibrin Regulation Enzymes..
Surg Innov. 24(6), 543-551.
(2017). Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).
(2018).